Shankar Gauri, Akhter Yusuf
Department of Biotechnology, Babasaheb Bhimrao Ambedkar University, Vidya Vihar, Raebareli Road, Lucknow, Uttar Pradesh, 226 025, India.
Department of Biotechnology, Babasaheb Bhimrao Ambedkar University, Vidya Vihar, Raebareli Road, Lucknow, Uttar Pradesh, 226 025, India.
Biochimie. 2024 Dec;227(Pt A):37-60. doi: 10.1016/j.biochi.2024.06.006. Epub 2024 Jun 18.
Mycobacterium tuberculosis (Mtb), the causative agent of tuberculosis (TB), faces iron scarcity within the host due to immune defenses. This review explores the importance of iron for Mtb and its strategies to overcome iron restriction. We discuss how the host limits iron as an innate immune response and how Mtb utilizes various iron acquisition systems, particularly the siderophore-mediated pathway. The review illustrates the structure and biosynthesis of mycobactin, a key siderophore in Mtb, and the regulation of its production. We explore the potential of targeting siderophore biosynthesis and uptake as a novel therapeutic approach for TB. Finally, we summarize current knowledge on Mtb's iron acquisition and highlight promising directions for future research to exploit this pathway for developing new TB interventions.
结核分枝杆菌(Mtb)是结核病(TB)的病原体,由于免疫防御作用,它在宿主体内面临铁缺乏的情况。本综述探讨了铁对结核分枝杆菌的重要性及其克服铁限制的策略。我们讨论了宿主如何将限制铁作为一种先天性免疫反应,以及结核分枝杆菌如何利用各种铁获取系统,特别是铁载体介导的途径。该综述阐述了分枝杆菌素(一种在结核分枝杆菌中关键的铁载体)的结构和生物合成,以及其产生的调控。我们探索了将靶向铁载体生物合成和摄取作为结核病新治疗方法的潜力。最后,我们总结了目前关于结核分枝杆菌铁获取的知识,并强调了未来研究利用该途径开发新的结核病干预措施的有前景的方向。